IPO GMP is the grey market premium — here is what it actually tells you about a stock before listing, and when to ignore it entirely.
Team Sahi
Every IPO season in India, one number gets passed around more than any other: the GMP. Investors check it on WhatsApp groups, IPO tracking websites, and financial forums before deciding whether to apply. But what exactly is IPO GMP, how is it calculated, and should you actually use it to make investment decisions?
This guide covers everything you need to know about IPO GMP — from the mechanics of the grey market to the honest data on how reliable it actually is.
GMP stands for Grey Market Premium. It is the price at which IPO shares trade in the unofficial grey market before the stock gets listed on the stock exchange.
Here is how it works:
The grey market exists because there is demand from investors who want to buy or sell IPO shares before listing, either to lock in gains or exit without waiting for the official listing day.
The grey market is entirely informal. There are no official exchanges, no SEBI oversight, and no legal contracts. Transactions happen through brokers who specialize in this market, and settlement is based on trust.
Two main activities happen in the grey market:
This is the price paid for an entire IPO application, regardless of allotment. If someone pays a kostak of ₹2,000 for your IPO application, they are buying your application form. If you get an allotment, they take the shares at the issue price; if not, they pay you nothing extra (since no allotment happened).
This is trading of shares at a premium above the issue price, contingent on the applicant receiving allotment. If GMP is ₹150 and the issue price is ₹400, the buyer agrees to pay ₹550 for each share, but only if allotment happens.
Both mechanisms give traders a way to price the expected listing performance before any official data exists.
GMP is tracked on several unofficial websites that aggregate reports from grey market participants. These sites update GMP in near-real-time as IPO subscription periods run. Common platforms where GMP data is reported include:
The GMP listed on these sites is crowd-sourced from brokers and participants active in the grey market — it is an estimate, not an official figure.
A high GMP suggests strong demand in the grey market for that IPO. When the GMP is, say, 50% above the issue price, it typically means:
Conversely, a negative GMP (trading below issue price) or a GMP near zero suggests weak demand and a possible listing below the issue price.
This is the question most retail investors should ask before acting on GMP. The honest answer: GMP has a signal, but it is far from definitive.
Here is what the data shows:
Both GMP and subscription rates are indicators of IPO demand, but they measure different things:
| Indicator | What It Measures | Reliability |
|---|---|---|
| GMP | Unofficial grey market demand and expected listing price | Moderate — directionally useful, can be manipulated in SMEs |
| QIB Subscription | Institutional investor demand (most informed buyers) | High — institutions do deep due diligence before bidding |
| HNI Subscription | High net worth individual demand (often leveraged bids) | Moderate — can be skewed by leverage |
| Retail Subscription | Retail investor demand | Lower — often driven by hype rather than fundamentals |
The strongest signal for a good listing is a combination of: high GMP + very high QIB subscription (50x or more) + strong overall oversubscription.
Should you apply to an IPO only because of a high GMP? No. GMP tells you what the grey market thinks, not what the company is worth.
Here is the right way to use GMP:
Once the IPO lists, the grey market ceases to be relevant for that stock. The share price on NSE/BSE becomes the real price. Grey market trading for that IPO effectively ends on listing day.
However, GMP data from past IPOs is useful. If you track how often actual listing prices matched GMP predictions for a given category of IPOs, you build a better intuition for how much weight to give GMP in the future.
Applying purely on GMP hype: Many retail investors see a 70-80% GMP and apply without reading the prospectus. This is speculation, not investing.
Trusting SME IPO GMPs: As discussed, the SME grey market is thin and prone to manipulation. Treat SME GMPs with significant skepticism.
Ignoring market conditions: A stock with a 50% GMP can still list below issue price if the Nifty drops 3-4% in the days before listing.
Selling based on early GMP data: GMP set during the IPO subscription period is often unreliable. Wait for the GMP closer to listing day, when it reflects more complete information.
IPO GMP is a useful but imperfect indicator. It captures sentiment and unofficial demand, and when combined with strong institutional subscription and solid company fundamentals, it can provide a reasonable signal for listing day performance.
Use it as one data point in your IPO decision — not as the deciding factor. The grey market reflects opinion, not certainty.
Want to apply for IPOs with ease? Open your account on Sahi and access upcoming IPOs, subscription data, and allotment status all in one place.
A negative GMP means the grey market expects the stock to list below the issue price. This is a warning signal, though not a guarantee of poor listing.
The grey market is unregulated and operates outside SEBI's framework. It is not officially sanctioned, and trades are not legally enforceable. SEBI has cautioned investors against grey market participation.
For large-cap mainboard IPOs with high institutional subscription, GMP directional accuracy (whether listing gain or loss) is approximately 60-70%. For SME IPOs, reliability drops significantly.
GMP data is available for most mainboard IPOs. For smaller SME IPOs, grey market activity may be minimal or unreported.
That depends on your investment thesis. If you applied for listing gains, a high GMP close to listing day supports selling on listing. If you applied for long-term holding, listing day price — whether it matches GMP or not — may not be your trigger to sell.